Jan. 30 at 10:34 PM
$CRIS Unfortunately, they did this 5 years ago and con'd me into buying shares at
$6.22, then plummeted down to like
$0.35 a share. Then they did a 20 to1 reverse split. Here we are again under
$1. We are no closer to a drug hitting the market. The price can only stay under
$1 for so long before the Nasdaq gives us the boot.